San Diego, CA -- (SBWIRE) -- 09/17/2020 -- An investigation was announced over potential securities laws violations by Poseida Therapeutics, Inc.

Investors who purchased shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Poseida Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Poseida Therapeutics, Inc. (NASDAQ: PSTX) completed its initial public offering ("IPO") on July 10, 2020, issuing 14 million shares of common stock at $16.00 per share.

Poseida Therapeutics, Inc. then disclosed on August 18, 2020, that the FDA had placed a clinical hold on its Phase 1 clinical trial of the autologous CAR-T therapy P-PSMA-101 in patients with metastatic castration-resistant prostate cancer. The hold is reportedly to investigate a patient's death that occurred in July.

Shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) declined to as low as $7.63 per share on August 24, 2020.

Those who purchased shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.